Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity
Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6...
medications
WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
Updated Oct. 20, 2023 11:00 am ETCVS Health is pulling some of the most common decongestants from its shelves and...
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Walgreens Lowers Financial Outlook Amid Weaker Retail Consumer Spending
The drugstore chain says it will step up cost-cutting measures and boost the long-term profitability of its healthcare business. Source...
No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming
Tablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require. Source link
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Americans to Be Barred From Buying Ozempic in British Columbia
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose...
Moderna’s Earnings, Revenue Fall on Fewer Covid Vaccine Sales
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Why You Can’t Find Wegovy, the Weight-Loss Drug
BusinessHealth CareHealthNovo Nordisk underestimated demand for drug that went viral on TikTok and YouTube Source link
Merck Is Coming for Pfizer’s Pneumonia Vaccine Market Share
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data
Enochian BioSciences Inc. has sued co-founder Serhat Gumrukcu for contractual fraud, alleging that it paid him and his husband $25...
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month
The drug, called Relyvrio, was approved by the Food and Drug Administration late Thursday after some staff had raised questions...
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
